Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 21, 2023

BUY
$0.35 - $3.28 $4,235 - $39,688
12,100 Added 24.1%
62,300 $22,000
Q1 2023

May 09, 2023

BUY
$3.28 - $4.81 $983 - $1,442
300 Added 0.6%
50,200 $174,000
Q4 2022

Jan 26, 2023

SELL
$3.65 - $4.82 $365 - $482
-100 Reduced 0.2%
49,900 $224,000
Q3 2022

Oct 24, 2022

BUY
$2.66 - $3.97 $17,290 - $25,805
6,500 Added 14.94%
50,000 $182,000
Q2 2022

Jul 29, 2022

BUY
$2.42 - $4.05 $24,926 - $41,715
10,300 Added 31.02%
43,500 $115,000
Q1 2022

Apr 20, 2022

BUY
$3.45 - $5.83 $25,875 - $43,725
7,500 Added 29.18%
33,200 $130,000
Q4 2021

Feb 10, 2022

BUY
$4.89 - $7.59 $977 - $1,518
200 Added 0.78%
25,700 $142,000
Q1 2021

Apr 28, 2021

SELL
$4.03 - $7.25 $22,769 - $40,962
-5,650 Reduced 18.14%
25,500 $111,000
Q4 2020

Feb 09, 2021

SELL
$2.78 - $4.5 $12,510 - $20,250
-4,500 Reduced 12.62%
31,150 $119,000
Q3 2020

Oct 28, 2020

SELL
$2.12 - $3.53 $81,514 - $135,728
-38,450 Reduced 51.89%
35,650 $125,000
Q1 2020

Apr 29, 2020

SELL
$1.35 - $4.05 $5,940 - $17,820
-4,400 Reduced 5.61%
74,100 $185,000
Q4 2019

Feb 03, 2020

BUY
$2.3 - $4.6 $44,620 - $89,240
19,400 Added 32.83%
78,500 $331,000
Q3 2019

Oct 23, 2019

SELL
$2.9 - $9.56 $40,310 - $132,884
-13,900 Reduced 19.04%
59,100 $171,000
Q2 2019

Aug 09, 2019

BUY
$6.7 - $9.13 $4,020 - $5,478
600 Added 0.83%
73,000 $643,000
Q1 2019

Apr 22, 2019

SELL
$5.7 - $8.73 $32,347 - $49,542
-5,675 Reduced 7.27%
72,400 $535,000
Q4 2018

Feb 11, 2019

SELL
$5.04 - $10.28 $803,754 - $1.64 Million
-159,475 Reduced 67.13%
78,075 $474,000
Q3 2018

Oct 22, 2018

BUY
$7.12 - $12.44 $571,024 - $997,688
80,200 Added 50.97%
237,550 $2.22 Million
Q2 2018

Aug 02, 2018

BUY
$6.21 - $8.21 $977,143 - $1.29 Million
157,350 New
157,350 $1.09 Million

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.